Edition:
India

Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

13.43USD
1:30am IST
Change (% chg)

$-0.01 (-0.07%)
Prev Close
$13.44
Open
$13.40
Day's High
$13.60
Day's Low
$13.38
Volume
80,967
Avg. Vol
140,624
52-wk High
$23.01
52-wk Low
$12.69

Latest Key Developments (Source: Significant Developments)

Codexis Reports Q2 2019 Results
Wednesday, 7 Aug 2019 

Aug 6 (Reuters) - Codexis Inc ::CODEXIS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 NON-GAAP LOSS PER SHARE $0.08.Q2 LOSS PER SHARE $0.12.Q2 REVENUE $12.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $14.2 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $69 MILLION TO $72 MILLION.AFFIRMING ITS FINANCIAL GUIDANCE FOR 2019.FY2019 REVENUE VIEW $70.5 MILLION -- REFINITIV IBES DATA.  Full Article

Codexis Inc - Announces Signing Of A Codeevolver Platform Agreement With Novartis
Wednesday, 15 May 2019 

May 15 (Reuters) - Codexis Inc ::CODEXIS INC - ANNOUNCES SIGNING OF A CODEEVOLVER PLATFORM AGREEMENT WITH NOVARTIS.CODEXIS - UNDER TERMS, NOVARTIS WILL PAY CO UPFRONT PAYMENT, MILESTONE PAYMENTS UPON SATISFACTORY COMPLETION OF TECHNOLOGY TRANSFER.CODEXIS - WILL BE ELIGIBLE TO GET PAYMENTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS MADE WITH ENZYMES DEVELOPED BY NOVARTIS USING CODEEVOLVER TECHNOLOGY.CODEXIS INC - RECEIVES CERTAIN RIGHTS FOR FUTURE PURCHASES OF ENZYMES DEVELOPED & SOURCED BY NOVARTIS USING CODEEVOLVER TECHNOLOGY.  Full Article

Codexis Entered Into Platform Technology Transfer And License Agreement With Novartis
Tuesday, 7 May 2019 

May 6 (Reuters) - Codexis Inc ::CODEXIS INC - ON MAY 2, 2019 ENTERED INTO PLATFORM TECHNOLOGY TRANSFER AND LICENSE AGREEMENT WITH NOVARTIS PHARMA AG - SEC FILING.CODEXIS -UNDER AGREEMENT,GRANTED TO NOVARTIS WORLDWIDE LICENSE TO USE CO'S CODEEVOLVER PLATFORM TECHNOLOGY TO RESEARCH, DEVELOP,MANUFACTURE NOVEL ENZYMES.CODEXIS INC -UNDER AGREEMENT, NOVARTIS WILL PAY CODEXIS UP TO $14 MILLION OVER APPROXIMATELY NEXT 22 MONTHS.CODEXIS - IF NOVARTIS EXERCISES TERMINATION RIGHT BEFORE MAKING FIRST TECHNOLOGY TRANSFER MILESTONE PAYMENT, NOVARTIS TO MAKE 1-TIME TERMINATION PAYMENT OF $9 MILLION.CODEXIS - IF NOVARTIS EXERCISES TERMINATION RIGHT BEFORE MAKING SECOND TECHNOLOGY TRANSFER MILESTONE PAYMENT, NOVARTIS TO MAKE 1-TIME TERMINATION PAYMENT OF $5 MILLION.  Full Article

Codexis Signs Multi-Year Enzyme Supply And Licensing Agreement
Tuesday, 30 Apr 2019 

April 30 (Reuters) - Codexis Inc ::CODEXIS SIGNS MULTI-YEAR ENZYME SUPPLY AND LICENSING AGREEMENT WITH TATE & LYLE FOR THE MANUFACTURE OF TASTEVA® M STEVIA SWEETENER.CODEXIS - MULTI-YEAR DEAL WITH TATE & LYLE FOR SUPPLY, LICENSING OF NOVEL CODEXIS PERFORMANCE ENZYMES USED IN MANUFACTURE OF TATE & LYLE'S TASTEVA.  Full Article

Codexis Q3 Non-Gaap Earnings Per Share $0.00
Friday, 9 Nov 2018 

Nov 8 (Reuters) - Codexis Inc ::CODEXIS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.00.Q3 LOSS PER SHARE $0.04.Q3 REVENUE $16.9 MILLION VERSUS I/B/E/S VIEW $14.8 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.07 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE $60 MILLION TO $62 MILLION.FY2018 REVENUE VIEW $62.3 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Porton Fine Chemicals signs strategic agreement with Codexis on enzymatic related business
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Porton Fine Chemicals Ltd <300363.SZ> ::Says it signed strategic agreement with U.S. company Codexis Inc <<>> on enzymatic related business .  Full Article

Codexis Announces Pricing Of Public Offering Of Common Stock
Friday, 6 Apr 2018 

April 6 (Reuters) - Codexis Inc ::CODEXIS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.75 MILLION COMMON SHARES PRICED AT $9.25PER SHARE.  Full Article

Codexis Q4 Non-Gaap Earnings Per Share $0.06
Friday, 9 Mar 2018 

March 8 (Reuters) - Codexis Inc ::CODEXIS REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.06.Q4 EARNINGS PER SHARE $0.02.Q4 EARNINGS PER SHARE VIEW $0.05 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE $60 MILLION TO $63 MILLION.‍TOTAL REVENUES FOR Q4 OF 2017 INCREASED 118% TO $21.7 MILLION FROM $10.0 MILLION FOR Q4 OF 2016​.SEES ‍ 2018 PRODUCT SALES ARE EXPECTED TO BE $25 MILLION TO $28 MILLION​.SEES ‍2018 GROSS MARGIN ON PRODUCT SALES IS EXPECTED TO BE 45% TO 48%​.FY2018 REVENUE VIEW $68.6 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $23.0 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Telemark Asset Management LLC reports 6.72 pct passive stake in Codexis ‍​as of Nov 10
Tuesday, 21 Nov 2017 

Nov 20 (Reuters) - Codexis Inc :Telemark Asset Management LLC reports 6.72 percent passive stake in Codexis Inc ‍​as of November 10 - SEC Filing.  Full Article

Codexis Q3 non-gaap loss per share $0.17
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Codexis Inc ::Codexis reports financial results for the third quarter of 2017.Q3 non-gaap loss per share $0.17.Q3 loss per share $0.21.Sees FY 2017 revenue $50 million to $53 million.Q3 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S.Codexis Inc - ‍total revenues for Q3 of 2017 were $10.0 million compared with $14.9 million for q3 of 2016​.Codexis Inc - ‍gross margin on product sales is expected to be between 40% and 43% for 2017​.  Full Article